Nathalie Baudson

643 total citations
19 papers, 520 citations indexed

About

Nathalie Baudson is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Nathalie Baudson has authored 19 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Nathalie Baudson's work include Immunotherapy and Immune Responses (11 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Nathalie Baudson is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Nathalie Baudson collaborates with scholars based in Belgium, United Kingdom and United States. Nathalie Baudson's co-authors include Catherine Gérard, Neil L. Spector, Wenle Xia, Lei-Hua Liu, Thierry Velu, Catherine Bruyns, Jean‐Louis Dargent, Nathalie Garçon, Anne Delvaux and Michel Goldman and has published in prestigious journals such as PLoS ONE, Oncogene and Investigative Ophthalmology & Visual Science.

In The Last Decade

Nathalie Baudson

18 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathalie Baudson Belgium	11	269	189	171	119	86	19	520
Gina Choe United States	8	158 0.6×	353 1.9×	193 1.1×	69 0.6×	40 0.5×	11	566
Annaelisa Tasciotti Italy	8	222 0.8×	199 1.1×	103 0.6×	176 1.5×	80 0.9×	13	435
György Stuber Sweden	14	334 1.2×	468 2.5×	149 0.9×	55 0.5×	141 1.6×	22	716
Li-Chung Tsao United States	10	188 0.7×	275 1.5×	140 0.8×	113 0.9×	65 0.8×	16	560
K. Jurianz Germany	8	81 0.3×	312 1.7×	130 0.8×	103 0.9×	56 0.7×	10	469
Alfons J. van den Eertwegh Netherlands	12	257 1.0×	545 2.9×	118 0.7×	88 0.7×	53 0.6×	24	729
Bernd Hubner Germany	9	73 0.3×	256 1.4×	276 1.6×	211 1.8×	48 0.6×	15	579
Longchao Liu United States	12	280 1.0×	460 2.4×	246 1.4×	54 0.5×	212 2.5×	18	758
Dirk M. van der Steen Netherlands	14	440 1.6×	432 2.3×	283 1.7×	49 0.4×	62 0.7×	28	747
Zane C. Neal United States	12	167 0.6×	255 1.3×	162 0.9×	67 0.6×	34 0.4×	17	445

Countries citing papers authored by Nathalie Baudson

Since Specialization

Citations

This map shows the geographic impact of Nathalie Baudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Baudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Baudson more than expected).

Fields of papers citing papers by Nathalie Baudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Baudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Baudson. The network helps show where Nathalie Baudson may publish in the future.

Co-authorship network of co-authors of Nathalie Baudson

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Baudson. A scholar is included among the top collaborators of Nathalie Baudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Baudson. Nathalie Baudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wilkinson, Tom, Peter van Steen, Brigitte Cheuvart, et al.. (2021). Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort. COPD Journal of Chronic Obstructive Pulmonary Disease. 18(3). 341–348. 13 indexed citations

Galustyan, A.N., et al.. (2020). Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. Human Vaccines & Immunotherapeutics. 16(9). 2265–2273. 3 indexed citations

Meyer, Nadia, et al.. (2020). Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study. Human Vaccines & Immunotherapeutics. 17(3). 723–730. 3 indexed citations

Mukherjee, Piyali, et al.. (2020). Late Breaking Abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients. 4927–4927. 3 indexed citations

Gérard, Catherine, et al.. (2015). A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors. Journal of Immunotherapy. 38(8). 311–320. 10 indexed citations

Garçon, Nathalie, C. Frieke Kuper, Nathalie Baudson, et al.. (2015). Non‐clinical safety evaluation of repeated intramuscular administration of the AS15 immunostimulant combined with various antigens in rabbits and cynomolgus monkeys. Journal of Applied Toxicology. 36(2). 238–256. 10 indexed citations

Destexhe, Éric, Owen K. Wilby, Nathalie Baudson, et al.. (2014). Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment. Reproductive Toxicology. 51. 90–105. 10 indexed citations

Destexhe, Éric, Nathalie Baudson, Roy Forster, et al.. (2014). Non‐clinical safety evaluation of single and repeated intramuscular administrations of MAGE‐A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys. Journal of Applied Toxicology. 35(7). 717–728. 10 indexed citations

Gérard, Catherine, et al.. (2014). Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses. PLoS ONE. 9(5). e94883–e94883. 24 indexed citations

10.

Baudson, Nathalie, et al.. (2006). 118 POSTER Comprehensive preclinical model evaluating a protein-based MAGE-A3 specific cancer immunotherapy to fight against MAGE-A3 expressing tumors. European Journal of Cancer Supplements. 4(12). 39–39.

11.

Xia, Wenle, et al.. (2005). Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells. Oncogene. 24(41). 6213–6221. 211 indexed citations

12.

Gérard, Catherine, et al.. (2001). Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 7(3 Suppl). 838s–847s. 11 indexed citations

13.

Gérard, Catherine, Nathalie Baudson, Claudine Bruck, et al.. (2001). Therapeutic potential of protein and adjuvant vaccinations on tumour growth. Vaccine. 19(17-19). 2583–2589. 58 indexed citations

14.

Grignet‐Debrus, Christine, et al.. (2000). The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy. Cancer Gene Therapy. 7(11). 1456–1468. 18 indexed citations

15.

Caspers-Velu, L, Nathalie Baudson, C Dubois, et al.. (2000). Role and expression of CD40 on human retinal pigment epithelial cells.. PubMed. 41(11). 3485–91. 25 indexed citations

16.

Grignet‐Debrus, Christine, Nathalie Baudson, Bart Degrève, et al.. (2000). Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Cancer Gene Therapy. 7(2). 215–223. 11 indexed citations

17.

Willermain, François, Catherine Bruyns, Malika Hamdane, et al.. (1999). Ligation of CD-40 on human retinal pigment epithelial cells in vitro does not induce a complete antigen-pesenting cell phenotype. Investigative Ophthalmology & Visual Science. 40(4). 859. 2 indexed citations

18.

Gérard, Catherine, Catherine Bruyns, Anne Delvaux, et al.. (1996). Loss of Tumorigenicity and Increased Immunogenicity Induced by Interleukin-10 Gene Transfer in B16 Melanoma Cells. Human Gene Therapy. 7(1). 23–31. 69 indexed citations

19.

Pirotte, Benoît, Catherine Gérard, Jean‐Louis Dargent, et al.. (1996). Curative Potential of Herpes Simplex Virus Thymidine Kinase Gene Transfer in Rats with 9L Gliosarcoma. Human Gene Therapy. 7(5). 627–635. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact